Optimizing the Interval Between Cycles of PRRT with 177lu-dotatate in Sstr2 Positive Tumors
Clinical trial NCT03454763 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03454763
- Sponsor
- Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-26
- Primary completion
- 2025-01-01
- Enrollment
- 618
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.